NCT04270188

Brief Summary

Prolapse is a pathology that can cause pelvic, urinary or sexual functional disorders and impaired quality of life. Although the use of vaginal mesh is a commonly practiced technique to correct prolapse, in recent years health officials have pointed to the lack of adequate safety and tolerability assessments of these implants. Currently, surgeons are therefore moving towards techniques without implants. The standard vaginal technique for the treatment of uterine prolapse is sacrospinofixation according to Richter. This technique can be performed without an implant, using autologous tissue. Functional discomfort of patients is the main problem linked to the presence of prolapse. However, no study has yet evaluated the feelings of patients following the use of this sacrospinofixation technique by autologous tissues by vaginal route, which led us to set up this study. The hypothesis is that the technique of anterior sacrospinofixation by autologous tissues improves the symptoms experienced by patients with an mid-level and / or anterior genital prolapse.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 17, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

July 21, 2020

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 28, 2025

Completed
Last Updated

March 6, 2026

Status Verified

March 1, 2026

Enrollment Period

5.3 years

First QC Date

February 12, 2020

Last Update Submit

March 5, 2026

Conditions

Keywords

middle anterior prolapse ≥ II (POP-Q classification)anterior prolapse ≥ II (POP-Q classification)

Outcome Measures

Primary Outcomes (1)

  • improvement of symptoms

    percentage of patients with symptom change on the PGI-I scale (score 1, 2, or 3)

    at Month 2

Study Arms (1)

anterior sacrospinofixation with autologous tissue

patients with middle and / or anterior prolapse ≥ II in the POP-Q classification and for whom an intervention by anterior sacrospinofixation by autologous tissues is planned.

Other: evolution of patient symptoms

Interventions

evolution of symptoms on the PGI-I scale (score 1, 2, or 3) 2 months after surgery

anterior sacrospinofixation with autologous tissue

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients over 18 years old with middle and / or anterior prolapse ≥ II in the POP-Q classification and for whom an intervention by anterior sacrospinofixation by autologous tissues is planned.

You may qualify if:

  • women over 18
  • middle and / or anterior genital prolapse (hysterocele and / or cystocele) requiring surgical correction of stage ≥ II in the POP-Q classification
  • patients wanting an intervention because of the discomfort caused by the prolapse
  • intervention planned by anterior sacrospinofixation by autologous tissues
  • person having expressed his non-opposition

You may not qualify if:

  • prolapse of stage \< II in the POP-Q classification, or prolapse without functional impairment
  • disorders involving an unacceptable risk of postoperative complications sought after questioning of the patient (blood coagulation disorders, immune system disorders, progressive diseases, etc.)
  • reduced mobility of the lower limbs (not allowing positioning for surgery)
  • pregnancy or any pregnancy plan for the duration of the study
  • active or latent infection
  • inability to understand the information given
  • person deprived of liberty, under guardianship.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon

Bron, 69500, France

Location

MeSH Terms

Conditions

Pelvic Organ Prolapse

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Géry LAMBLIN, MD

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2020

First Posted

February 17, 2020

Study Start

July 21, 2020

Primary Completion

October 28, 2025

Study Completion

October 28, 2025

Last Updated

March 6, 2026

Record last verified: 2026-03

Locations